Jochem Wassing

Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial

Elvin Kedhi, Kaiyum Sheik Joesoef, Eugène McFadden et al. · The Lancet · 2010 · 687 citations

Medicine, Cardiology, Interventional Cardiology +9

2-Year Follow-Up of a Randomized Controlled Trial of Everolimus- and Paclitaxel-Eluting Stents for Coronary Revascularization in Daily Practice

Pieter C. Smits, Elvin Kedhi, Kees‐Jan Royaards et al. · Journal of the American College of Cardiology · 2011 · 193 citations

Medicine, Cardiology, Surgery +17

Final 5-Year Follow-Up of a Randomized Controlled Trial of Everolimus- and Paclitaxel-Eluting Stents for Coronary Revascularization in Daily Practice

Pieter C. Smits, Georgios J. Vlachojannis, Eugène McFadden et al. · JACC: Cardiovascular Interventions · 2015 · 125 citations · Full text

Medicine, Cardiology, Surgery +15

Everolimus-eluting stents and paclitaxel-eluting stents in patients presenting with myocardial infarction: insights from the two-year results of the COMPARE prospective randomised controlled trial

Elvin Kedhi, Marc E. Gomes, Kaiyum Sheik Joesoef et al. · EuroIntervention · 2012 · 33 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

Abluminal biodegradable polymer biolimus-eluting versus durable polymer everolimus-eluting stent in patients with diabetes mellitus

Valeria Paradies, Georgios J. Vlachojannis, Kees‐Jan Royaards et al. · International Journal of Cardiology · 2019 · 11 citations · Full text

Medicine, Cardiology, Surgery +17